CF-sensing catheter ablation of AF can reduce the incidence of major complications and generate better outcomes compared with NCF-sensing catheters during the 12-month follow-up period
Contact force ( CF ) monitoring can be useful in accomplishing circumferential pulmonary vein ( PV ) isolation for atrial fibrillation ( AF ) .
This meta- analysis aim ed to assess the efficacy and safety of a CF-sensing catheter in treating AF .
Use of a contact force-sensing ablation catheter with advanced catheter location significantly reduces fluoroscopy time and radiation dose in catheter ablation of atrial fibrillation.
AIMS The aim of this study was to evaluate the ' real-world ' impact of a novel contact force (CF)-sensing ( SmartTouch ™ , Biosense Webster , Diamond Bar , CA , USA ) catheter coupled with an advanced catheter location ( ACL ) system on fluoroscopy time and fluoroscopy dose during atrial fibrillation ( AF ) ablation . METHODS AND RESULTS This was a retrospective observational cohort study of prospect ively collected data of 1515 consecutive patients undergoing paroxysmal AF ( PAF ) and persistent AF ( PerAF ) ablation at a single institution between 2009 and 2014 . Patients undergoing AF ablation with the SmartTouch catheter and the ACL system ( SmartTouch group , n = 510 ) were compared with those undergoing AF ablation without this technology ( control group , n = 1005 ) . The primary outcomes were total fluoroscopy time ( min ) and fluoroscopy dose as measured by the dose-area product ( mGy cm(2 ) ) . Secondary endpoints included total procedure time , total ablation time , and major cardiac complications ( tamponade , pericardial effusion , and urgent cardiac surgery ) . The SmartTouch group had significantly lower fluoroscopy times ( 9.5 vs. 41 min , P < 0.001 ) , radiation doses ( 1044 vs. 3571 mGy cm(2 ) , P < 0.001 ) , and shorter procedural time ( 195 vs. 240 min , P < 0.001 ) when compared with the control group . This was statistically significant for both PAF and PerAF ablations and for both de novo and redo AF procedures . After a learning curve , a median fluoroscopy time of 3.5 min ( interquartile range 6 ) for all AF ablations was achieved . There was no difference in the rate of cardiac complications ( ∼ 1.5 % ) . CONCLUSION SmartTouch ™ CF-sensing catheter use with ACL ™ during AF ablation significantly reduces fluoroscopy times by 77 % , radiation dose by 71 % , and procedural time by 19 % but does not improve overall safety or the risk of cardiac complications
CF-sensing catheter ablation of AF can reduce the incidence of major complications and generate better outcomes compared with NCF-sensing catheters during the 12-month follow-up period
Contact force ( CF ) monitoring can be useful in accomplishing circumferential pulmonary vein ( PV ) isolation for atrial fibrillation ( AF ) .
This meta- analysis aim ed to assess the efficacy and safety of a CF-sensing catheter in treating AF .